$15.14
Today
as of Sep 4, 16:48 ET
Last 30 days
Recent Press Releases & News
Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference
Wall Street Moves on MAA, Rivian and Design Therapeutics: One Upgrade, One Target Trim and a Biotech on Watch
Design Therapeutics Q2 Net Loss Narrows
Overview
52-week range
$5.28
$17
82% of range
Avg surprise (last 2)
-8.5%
Avg reaction (last 1)
-8.3%
0% positive
Latest IV / EM
162%
EM ±27.0% · $16 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.32 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.29 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.30 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.34 | $-0.32 | -6.2% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $-0.31 | $-0.28 | -10.7% | — | -8.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.23 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.21 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.20 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.28 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.36 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.35 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | — | — | — | $0 | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-22M | $-20M | — | $-19M | $-22M | $-20M | — | $-16M |
| Net income | $-20M | $-18M | — | $-17M | $-19M | $-18M | — | $-13M |
| EPS (diluted) | $-0.32 | $-0.29 | — | $-0.30 | $-0.34 | $-0.31 | — | $-0.23 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $13M | $13M | $17M | $15M | $20M | $14M | $23M | $30M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $212M | $227M | $224M | $209M | $220M | $234M | $248M | $257M |
| Total assets | $215M | $230M | $226M | $212M | $223M | $237M | $252M | $262M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $13M | $12M | $14M | $12M | $10M | $10M | $10M | $9M |
| Total equity | $202M | $218M | $213M | $200M | $213M | $228M | $242M | $252M |